ID

28085

Descripción

Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00806767

Link

https://clinicaltrials.gov/show/NCT00806767

Palabras clave

Versiones (1)
  1. 16/12/17 16/12/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

16 de diciembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Chronic Myeloproliferative Disorders NCT00806767

Inglés

Eligibility Chronic Myeloproliferative Disorders NCT00806767

1 formularios  
Criteria
Descripción

Criteria

diagnosis of a hematological malignancy
Descripción

Hematologic Neoplasm

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0376545
candidate for an allogeneic hematopoietic stem cell transplantation
Descripción

Allogeneic Hematopoietic Stem Cell Transplantation Scheduled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1705576
UMLS CUI [1,2]
C0205539
available hla-identical related donor
Descripción

Donor Relative HLA Antigens Match Available

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040288
UMLS CUI [1,2]
C0080103
UMLS CUI [1,3]
C0019721
UMLS CUI [1,4]
C1708943
UMLS CUI [1,5]
C0470187
patient characteristics:
Descripción

Client Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0815172
who performance status (ps) 0-1 or karnofsky ps 70-100%
Descripción

WHO performance status scale | Karnofsky Performance Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1298650
UMLS CUI [2]
C0206065
life expectancy > 6 months
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
lvef ≥ 40%
Descripción

Left ventricular ejection fraction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428772
dlco ≥ 50%
Descripción

Carbon Monoxide Diffusing Capability Test

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1516251
creatinine clearance ≥ 30 ml/min
Descripción

Creatinine clearance measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0373595
transaminases and/or bilirubin ≤ 2 times upper limit of normal (uln)
Descripción

Transaminases | Serum total bilirubin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0002594
UMLS CUI [2]
C1278039
no other cancer within the past 5 years, except for basal cell carcinoma of the skin or carcinoma in situ of the cervix
Descripción

Exclusion Cancer Other | Exception Basal cell carcinoma | Exception Carcinoma in situ of uterine cervix

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
no human t-cell leukemia virus type 1 positivity
Descripción

Exclusion | Human t-cell leukemia virus 1 Positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0020094
UMLS CUI [1,3]
C1514241
no hiv positivity
Descripción

Exclusion HIV Seropositivity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0019699
no uncontrolled bacterial, viral, or fungal infection
Descripción

Exclusion Criteria | Bacterial Infection Uncontrolled | Virus Disease Uncontrolled | Mycoses Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0004623
UMLS CUI [2,2]
C0205318
UMLS CUI [3,1]
C0042769
UMLS CUI [3,2]
C0205318
UMLS CUI [4,1]
C0026946
UMLS CUI [4,2]
C0205318
no contraindications to the study drugs
Descripción

Exclusion | Medical contraindication Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0013230
no concurrent serious and uncontrolled disease
Descripción

Exclusion | Comorbidity Serious Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0205318
prior concurrent therapy:
Descripción

Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0087111
at least 1 month since prior participation in a clinical trial
Descripción

Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
Volver a la parte superior de la página

Similar models

Eligibility Chronic Myeloproliferative Disorders NCT00806767

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Hematologic Neoplasm
Item
diagnosis of a hematological malignancy
boolean
C0376545 (UMLS CUI [1])
Allogeneic Hematopoietic Stem Cell Transplantation Scheduled
Item
candidate for an allogeneic hematopoietic stem cell transplantation
boolean
C1705576 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
Donor Relative HLA Antigens Match Available
Item
available hla-identical related donor
boolean
C0040288 (UMLS CUI [1,1])
C0080103 (UMLS CUI [1,2])
C0019721 (UMLS CUI [1,3])
C1708943 (UMLS CUI [1,4])
C0470187 (UMLS CUI [1,5])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
WHO performance status scale | Karnofsky Performance Status
Item
who performance status (ps) 0-1 or karnofsky ps 70-100%
boolean
C1298650 (UMLS CUI [1])
C0206065 (UMLS CUI [2])
Life Expectancy
Item
life expectancy > 6 months
boolean
C0023671 (UMLS CUI [1])
Left ventricular ejection fraction
Item
lvef ≥ 40%
boolean
C0428772 (UMLS CUI [1])
Carbon Monoxide Diffusing Capability Test
Item
dlco ≥ 50%
boolean
C1516251 (UMLS CUI [1])
Creatinine clearance measurement
Item
creatinine clearance ≥ 30 ml/min
boolean
C0373595 (UMLS CUI [1])
Transaminases | Serum total bilirubin measurement
Item
transaminases and/or bilirubin ≤ 2 times upper limit of normal (uln)
boolean
C0002594 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
Exclusion Cancer Other | Exception Basal cell carcinoma | Exception Carcinoma in situ of uterine cervix
Item
no other cancer within the past 5 years, except for basal cell carcinoma of the skin or carcinoma in situ of the cervix
boolean
C2828389 (UMLS CUI [1,1])
C1707251 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
Exclusion | Human t-cell leukemia virus 1 Positive
Item
no human t-cell leukemia virus type 1 positivity
boolean
C2828389 (UMLS CUI [1,1])
C0020094 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,3])
Exclusion HIV Seropositivity
Item
no hiv positivity
boolean
C2828389 (UMLS CUI [1,1])
C0019699 (UMLS CUI [1,2])
Exclusion Criteria | Bacterial Infection Uncontrolled | Virus Disease Uncontrolled | Mycoses Uncontrolled
Item
no uncontrolled bacterial, viral, or fungal infection
boolean
C0680251 (UMLS CUI [1])
C0004623 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0042769 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0026946 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
Exclusion | Medical contraindication Investigational New Drugs
Item
no contraindications to the study drugs
boolean
C2828389 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
Exclusion | Comorbidity Serious Uncontrolled
Item
no concurrent serious and uncontrolled disease
boolean
C2828389 (UMLS CUI [1])
C0009488 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0205318 (UMLS CUI [2,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Study Subject Participation Status
Item
at least 1 month since prior participation in a clinical trial
boolean
C2348568 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial